CA2428224C - Method of measuring platelet activation - Google Patents

Method of measuring platelet activation Download PDF

Info

Publication number
CA2428224C
CA2428224C CA2428224A CA2428224A CA2428224C CA 2428224 C CA2428224 C CA 2428224C CA 2428224 A CA2428224 A CA 2428224A CA 2428224 A CA2428224 A CA 2428224A CA 2428224 C CA2428224 C CA 2428224C
Authority
CA
Canada
Prior art keywords
platelet
blood
edta
anticoagulated
ctad
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2428224A
Other languages
English (en)
French (fr)
Other versions
CA2428224A1 (en
Inventor
Marion Glenys Macey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Barts and London NHS Trust
Original Assignee
Barts and London NHS Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barts and London NHS Trust filed Critical Barts and London NHS Trust
Publication of CA2428224A1 publication Critical patent/CA2428224A1/en
Application granted granted Critical
Publication of CA2428224C publication Critical patent/CA2428224C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
CA2428224A 2000-11-08 2001-11-08 Method of measuring platelet activation Expired - Fee Related CA2428224C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0027309.4A GB0027309D0 (en) 2000-11-08 2000-11-08 Method of measuring measuring platlet activation
GB0027309.4 2000-11-08
PCT/GB2001/004946 WO2002039124A1 (en) 2000-11-08 2001-11-08 Method of measuring platelet activation

Publications (2)

Publication Number Publication Date
CA2428224A1 CA2428224A1 (en) 2002-05-16
CA2428224C true CA2428224C (en) 2010-04-27

Family

ID=9902807

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2428224A Expired - Fee Related CA2428224C (en) 2000-11-08 2001-11-08 Method of measuring platelet activation

Country Status (9)

Country Link
US (1) US7011938B2 (enExample)
EP (1) EP1332373B1 (enExample)
JP (1) JP2004513369A (enExample)
AT (1) ATE522808T1 (enExample)
AU (2) AU2002212529B2 (enExample)
CA (1) CA2428224C (enExample)
ES (1) ES2372810T3 (enExample)
GB (1) GB0027309D0 (enExample)
WO (1) WO2002039124A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2392724A (en) * 2002-09-06 2004-03-10 Ian Stoakes Methods of and apparatus for blood analysis
EP1814563A4 (en) * 2004-07-26 2008-04-16 Bayer Healthcare Llc PLATTOCK ACTIVATING MARKERS AS PREDICATORS OF ILLNESSES AND THE RESPONSE TO TREATMENTS AND MONITORING THERAPEUTIC PROGRESS
US7811549B2 (en) 2006-07-05 2010-10-12 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
US8021854B2 (en) * 2007-10-05 2011-09-20 Attila Mady Method of treating vascular disease
US8835104B2 (en) * 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
WO2009092516A2 (en) * 2008-01-22 2009-07-30 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
WO2011140241A2 (en) 2010-05-04 2011-11-10 The General Hospital Corporation Methods and compositions for preserving tissues and organs
WO2012139017A1 (en) 2011-04-07 2012-10-11 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
EP3054936B1 (en) 2013-10-10 2023-10-18 Eastern Virginia Medical School 4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivatives as 12-lipoxygenase inhibitors
EP3698628A1 (en) 2014-08-07 2020-08-26 The General Hospital Corporation Stabilization of whole blood samples
US20180017584A1 (en) 2016-07-12 2018-01-18 Emulate Inc. Additive channels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08220094A (ja) * 1995-02-08 1996-08-30 Dai Ichi Pure Chem Co Ltd 血漿中ｇｍｐ−１４０の測定法
FR2731277A1 (fr) * 1995-03-02 1996-09-06 Benveniste Jacques Procedes et appareil pour faciliter la purification, le comptage et la mesure de l'activation des leucocytes sanguins
US5817519A (en) * 1995-12-28 1998-10-06 Bayer Corporation Automated method and device for identifying and quantifying platelets and for determining platelet activation state using whole blood samples
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease

Also Published As

Publication number Publication date
ES2372810T3 (es) 2012-01-26
WO2002039124A1 (en) 2002-05-16
EP1332373A1 (en) 2003-08-06
US20040038997A1 (en) 2004-02-26
AU1252902A (en) 2002-05-21
CA2428224A1 (en) 2002-05-16
GB0027309D0 (en) 2000-12-27
AU2002212529B2 (en) 2006-08-10
US7011938B2 (en) 2006-03-14
EP1332373B1 (en) 2011-08-31
ATE522808T1 (de) 2011-09-15
JP2004513369A (ja) 2004-04-30

Similar Documents

Publication Publication Date Title
Macey et al. Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system
Macey et al. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system
Harris et al. The ADVIA 2120 hematology system: flow cytometry-based analysis of blood and body fluids in the routine hematology laboratory
JP3704654B2 (ja) 全血サンプルを使用して血小板を同定および定量し、血小板の活性化状態を測定する高感度で正確かつ精密な自動化方法
Zelmanovic et al. Automated analysis of feline platelets in whole blood, including platelet count, mean platelet volume, and activation state
JP2565844B2 (ja) 細胞溶解処理条件下で異種細胞集団を正確に計数し，感受性に関する格付けを行う方法
Ahnadi et al. Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy
EP0545314B1 (en) Reagent compositions and their use in the identification and characterization of reticulocytes in whole blood
US5633167A (en) Reagent compositions for use in sphering cells
US5858790A (en) Hematology reference control and method of preparation
Lippi et al. Stability of blood cell counts, hematologic parameters and reticulocytes indexes on the Advia A120 hematologic analyzer
EP0869347A2 (en) Method and reagent for identification of reticulocytes, erythrocytes and platelets
US7449337B2 (en) Lytic reagent and method for leukocytes differential in whole blood
CA2428224C (en) Method of measuring platelet activation
Ault The clinical utility of flow cytometry in the study of platelets
AU2002212529A1 (en) Method of measuring platelet activation
Patton et al. A study of changes in red cell volume and haemoglobin concentration during phlebotomy induced iron deficiency and iron repletion using the Technicon H1
JP2004513369A5 (enExample)
EP2291652B1 (en) Stabilisation of blood cell conjugates
Chiron et al. The GEN. S: a fortuitous finding of a routine screening test for hereditary spherocytosis
Kangwende et al. Evaluating Blood Sample Storage Conditions And How It Can Affect Haematology Interpretation At The PAH
Nemec et al. The effect of high anticoagulant k3-edta concentration on complete blood count and white blood cell differential counts in healthy beagle dogs
Solanki et al. Spurious red blood cell parameters due to serum cold agglutinins: Observations on Ortho ELT-8® Cell Counter
Zsóri et al. Preanalytical factors affecting the mean platelet volume: a review
Briggs et al. Automated platelet analysis

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20131108